Anxiety Disorders
Samantha Meltzer-Brody, M.D., M.P.H.Assistant Professor
UNC Department of Psychiatry
Anxiety Nervousness and fear are common
human emotions. Adaptive at lower levels; disabling
at high levels. Physicians must recognize the
difference between pathological anxiety and anxiety as a normal or adaptive response.
Features of Pathologic Anxiety Autonomy: no or minimal
environmental trigger Intensity: exceeds patient’s
capacity to bear the discomfort Duration: symptoms are persistent Behavior: anxiety impairs coping
and results in disabling behaviors
Definition of Anxiety Diffuse, unpleasant, vague sense of
apprehension Often accompanied by autonomic
symptoms such as headache, perspiration, heart palpitations, chest tightness, stomach discomfort and restlessness
Presentation depends on perception of stress, personal resources, psychological defenses, and coping mechanisms
Etiology Neurophysiology
Central noradrenergic systems– in particular, the locus coeruleus is the major source of adrenergic innervation
GABA neurons from the limbic system Serotoninergic systems and neuropeptides
Cognitive-Behavioral Formulations Developmental (Psychodynamic)
Formulations
Anxiety Disorders The most prevalent psychiatric
disorders One-quarter of the U.S. population
experiences pathologic anxiety in their lifetime
Presenting problem for 11% of patients visiting primary care physicians
90% of patients with anxiety present with somatic complaints
Common Medical Conditions Associated with Anxiety Disorders
Endocrine: thyroid dysfunction, hyper adrenalism
Drug Intoxication: caffeine, cocaine
Drug Withdrawal: alcohol, narcotics
Hypoxia: CHF, angina, anemia, COPD
Metabolic: acidosis, hyperthermia
Neurological: seizures, vestibular dysfxn
Major Anxiety Disorders Panic Disorder Generalized Anxiety Disorder Post Traumatic Stress Disorder Social Phobia Specific Phobia Obsessive Compulsive Disorder (OCD) Substance Induced Anxiety Disorder
Panic Attack Discrete episodes of intense
anxiety Sudden onset Peak within 10 minutes Associated with at least 4 of the 13
other somatic or cognitive symptoms of autonomic arousal
Panic Attack Symptoms Cardiac: palpitations, tachycardia,
chest pain or discomfort Pulmonary: shortness of breath, a
feeling of choking GI: nausea or abdominal distress Neurological: trembling and
shaking, dizziness, lightheadedness or faintness, paresthesias
Panic Attack Symptoms Autonomic Arousal: sweating, chills
or hot flashes Psychological:
Derealization (feeling of unreality) Depersonalization (feeling detached
from oneself) Fear of losing control or going crazy Fear of dying
Panic Disorder A syndrome characterized by
recurrent unexpected panic attacks (at least 4 in one month)
Attacks are followed for at least one month with: Concern about having another attack Worry about implications of the attack Behavior changes because of the
attacks
Agoraphobia Complication of panic disorder Means “ fear of the market” Anxiety or avoidance of places or
situations from which escape might be difficult, embarrassing, or help may be unavailable.
Restricts daily activities
Agoraphobia Agoraphobia
The patient may avoid crowds, restaurants, highways, bridges, movie theaters etc.
In its most severe form, the patient may become dependent on companions to face situations outside the home.
Some individuals become homebound.
Epidemiology of Panic Disorder
Panic disorder has a lifetime prevalence of 1.5-3.5%
2:1 female/male ratio ? Of true gender difference versus
men tend to self-medicate with alcohol and are less likely to seek treatment.
Onset is late teens through third decade of life.
Differential Diagnosis of Panic Disorder Not due to another anxiety disorder Not due to effects of a general medical
condition Cardiovascular disease Pulmonary disease Neurological disease Endocrine disease Drug intoxication or withdrawal Other (lupus, infections, heavy metal
poisoning, uremia, temporal arteritis)
Panic Disorder: Costs 200,000 normal coronary angiograms/yr
in the U.S. at a cost of 600 million dollars: 1/3 of these patients have panic disorder
½ of patients referred for non-invasive testing for atypical chest pain and who have normal tests have panic disorder
1/3 patients undergoing work-up for vestibular disorder with c/o dizziness have panic disorder
Panic Disorder: Comorbidity
Panic disorder patients have an increased personal and family history of other anxiety, mood and substance abuse disorders.
Major depression is a co-morbid diagnosis in 1/3 of cases presenting for treatment
Untreated patients have high risk of suicide
Panic Disorder: Treatment About 80% of patients will respond
to treatment Antidepressant medications are
effective Serotonin reuptake inhibitors (SSRI)
are first line therapy Tricyclic antidepressants (TCA) and
monoamine oxidase inhibitors (MAOI’s) are also used.
Panic Disorder: Treatment Sedative-Hypnotics: benzodiazepines
are ideally used in the short term before an antidepressant has had time to work
Cognitive Behavioral Therapy (CBT): helps patients overcome a learned pattern of catastrophically misinterpreting the physical symptoms associated with panic attacks.
Generalized Anxiety Disorder (GAD) Patients with GAD suffer from
severe worry or anxiety that is out of proportion to situational factors.
Must last most days for at least 6 months
Described as “worriers” or “nervous”
GAD Symptoms include:
Muscle tension Restlessness Insomnia Difficulty concentrating Easy fatigability Irritability Persistent anxiety (rather than
discrete panic attacks)
GAD Diagnostic Criteria Excessive anxiety and worry that
occurs more days than not for 6 months
Difficult to control the worry 3 out of 6 symptoms Anxiety caused significant distress or
impairment in function Not attributed to another organic cause
GAD Epidemiology 5% prevalence in community
samples 2:1 female/male ratio Age of onset is frequently in
childhood or adolescence Chronic but fluctuating course of
illness (worsened during stressful periods)
GAD Treatment Cognitive Behavioral Therapy Other Psychotherapies Pharmacotherapy
Antidepressants Benzodiazepines Buspirone
Post Traumatic Stress Disorder (PTSD) Patients with PTSD have
experienced a trauma and develop disabling symptoms in response to the event.
Symptoms usually begin within 3 months of the trauma
Syndrome can occur at any age
Definition of Trauma The person experienced, witnessed
or learned of an event that involved actual or threatened death, serious injury, or threat of harm to self or others
The person’s response involved intense fear, helplessness or horror
Types of Trauma Sexual abuse Rape Physical abuse Severe motor vehicle
accidents Robbery/mugging Terrorist attack Combat veteran Natural disasters
Being diagnosed with a life threatening illness
Sudden unexpected death of family/friend
Witnessing violence (including domestic violence)
Learning one’s child has life threatening illness
Diagnosis of PTSD Symptoms must be > one month
duration and include:
Re-experiencing symptoms Avoidance symptoms Emotional numbing Hyperarousal symptoms
Re-experiencing Symptoms There are recurrent, intrusive thoughts
of the event (can’t not think about it) Dreams (nightmares) about the event Acting or feeling the event is recurring,
or sense of living the event (flashbacks) Psychological or Physiological Distress
upon exposure to reminders or cues of the event.
Avoidance/Numbing Symptoms Avoid thoughts, feelings, places or people
that arouse memories of the event Being unable to recall important parts of
the event Decrease interest in activities Feeling detached or estranged from
others Decreased range of affect Sense of foreshortened future
Hyperarousal Symptoms Patient experiences at least two of
the following: Insomnia (falling or staying asleep) Irritability or outbursts of anger Decreased concentration Hypervigilance Increased/exaggerated startle
response
Epidemiology of PTSD Prevalence is 1% in the general
population, and can be as high as 25% in those who have experienced trauma
In combat veterans, prevalence is 20%
Very high prevalence in women who are victims of sexual trauma
PTSD Costs Patients with PTSD are frequent
users of the health care system Patients usually present to primary
care physicians with somatic complaints
After panic disorder, PTSD is the most costly anxiety disorder
PTSD Treatment Psychotherapies
Exposure-based cognitive behavioral therapy Psychotherapy aimed at survivor anger, guilt
and helplessness (victimization) Pharmacological treatment targets the
reduction of prominent symptoms SSRI’s are first line therapy Atypical antipsychotics are being increasingly
used
Social Phobia Fear of being exposed to public
scrutiny Fear of behaving in a way which will
be humiliating or embarrassing Symptomatic resemblance to panic
disorder with anticipatory anxiety (person may be anxious/worrying far in advance of the event)
Extensive phobic avoidance
Social Phobia Distinction: anxiety only occurs
when the patient is subject to the scrutiny of others (public speaking, oral exam, eating in the cafeteria)
Phobic stimulus is avoided or endured with intense anxiety
Fear and avoidant behaviors interfere with person’s normal routine or cause marked distress
Epidemiology: Social Phobia Prevalence rates vary depending on
study; overall range is 3 –13% of the population
Onset in adolescence Prevalence greater in females, but
greater for males in clinical samples Frequent comorbidity with
depression and substance abuse
Social Phobia: Treatment Antidepressants, SSRI’s and MAOI’s High potency benzodiazepines Low doses of beta blockers are
helpful for public speaking (if only an occasional event); this alleviates the autonomic symptoms
Psychotherapy-cognitive restructuring
Specific Phobia Marked and persistent fear that is
excessive and unreasonable of a specific object or situation
Exposure to the phobic stimulus will provoke an anxiety response
Phobia Subtypes Animals or insects Natural environment– storms, water,
heights Blood, injury, injection, medical procedure Situational flying, driving, enclosed places Having a phobia of a specific subtype
increased the chances of having another phobia within that subtype
Epidemiology of Specific Phobias
Lifetime prevalence is 10% of the population
Age of onset varies with subtype Childhood onset for phobias of
animals, natural environments blood and injections
Bimodal distribution (childhood and mid-twenties for situational phobias
Specific Phobia Treatments Flooding-exposing the person to the
feared stimulus Exposure therapy works to
desensitize the patient using a series of gradual, self-paced exposures to the phobic stimulus; uses relaxation, hypnosis, breathing control and other cognitive approaches
Benzodiazepines or Beta blockers are useful acutely
Specific Phobia: Treatment Example: Fear of Flying
Visualize a plane. Look at a plane in the sky. Drive by an airport. Go to a museum that has planes. Same museum—visualize going inside. Go inside. Go to airport and watch planes take off and land. Visualize yourself on a plane flying. Omnimax theater experience. The real thing.
Obsessive Compulsive Disorder (OCD) Obsessions: recurrent, intrusive,
unwanted thoughts (i.e. fear of contamination)
Compulsions: behaviors or rituals aimed at reducing distress or preventing a dreaded event (i.e. compulsive handwashing)
OCD Symptoms Recurrent obsessions and/or
compulsions are severe enough to consume more than one hour/day
Person recognizes the obsession as a “product of his/her own mind”, rather than imposed from the outside, and that they are unreasonable or excessive
OCD Symptoms The obsessions are “ego-dystonic”
(not enjoyable for the ego), as opposed to “ego-syntonic” (the ego likes it)
Common Obsessions Contamination Repeated doubts Order Aggressive or horrific images Sexual/pornographic imagery Scrupulosity
Obsessions and Common Compulsive Responses Contamination: cleaning, hand washing,
showering Repeated doubts: checking, requesting
or demanding reassurances from others, counting
Order: checking, rituals, counting Aggressive or horrific images, checking,
prayers, rituals Sexual/Pornographic imagery:
prayer/rituals
Epidemiology of OCD Lifetime prevalence is 2-3% in the
general population Mean age of onset is mid-twenties,
although men may develop symptoms earlier
Less than 5% of patients develop disease after age of 35 years
Chronic course, stress can exacerbate symptoms
OCD Treatment Serotonin reuptake inhibitors Clomipramine, a serotonergic
tricyclic antidepressant Psychotherapy: exposure and
response prevention
OCD is not OCPD Obsessive-Compulsive Disorder is
different from obsessive compulsive personality disorder (OCPD)
OCPD: a pervasive pattern of preoccupation with orderliness, perfectionism and control that begins by early adulthood
Substance Induced Anxiety Disorder Prominent symptoms of anxiety
that are judged to be the direct physiological consequence of a drug or abuse, a medication or toxin exposure
Summary and Review of Anxiety Disorders
Panic Attacks and Panic Disorder
Panic Attacks Agoraphobia without a history of
panic disorder Panic Disorder without
agoraphobia Panic Disorder with agoraphobia
Generalized Anxiety Disorder Characterized by at least 6 months
of persistent and excessive anxiety and worry
Post Traumatic Stress Disorder Characterized by the re-experiencing of
an extremely traumatic event accompanied by symptoms of increased arousal and by avoidance of stimuli associated with the trauma
Symptoms present for at least one month If event just occurred and/or symptoms
present for less than one month, a diagnosis of Acute Stress Disorder is given
Social Phobia Clinically significant anxiety
provoked by exposure to certain types of social or performance situations, often leading to avoidance behavior
Specific Phobia Clinically significant anxiety
provoked by exposure to a specific feared object or situation, often leading to avoidance behavior
Obsessive Compulsive Disorder Characterized by obsessions that
cause marked anxiety or distress and/or compulsions that serve to neutralize anxiety
Substance Induced Anxiety Disorder
Anxiety Disorder not otherwise specified
Anxiety Disorder Association of American (ADAA) The ADAA brings together professionals
from many disciplines including psychiatrists, psychologists, social workers, physicians, nurses, etc. Through networks, the ADAA increases awareness about anxiety disorders, provides education resources, offers access to care, and supports research.
www.adaa.org